Using our tool helps you match your concerns to the treatments we offer
Related to 5-Amino-1-MQ Related articles Amlexanox Treatment Protocol Compounded NAD+ Treatment Protocol L-Carnitine Compounded + Branded DHEA Treatment Protocol Compounded + Branded Enclomiphene Treatment Protocol
They are not intended for human consumption, clinical use, diagnostic use, therapeutic use, veterinary use, cosmetic use, or dietary supplement use
By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis via the salvage pathway, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis, fat oxidation, and metabolic flexibility [3]
Realistic expectation: Users running microneedling plus GHK-Cu often see at week 8 what topical-only users see at week 12